Sign up today to learn more about Pear Therapeutics stock
EquityZen is a marketplace for shares of proven pre IPO tech companies
Pear Therapeutics Stock
Prescription Digital Therapeutics
About Pear Therapeutics Stock
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform aims to combine novel digital interventions with drugs to enhance efficacy, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians and cost-effective services for payers. The company has three FDA-approved products for substance use disorders, opioid use disorders, and insomnia.
Pear Therapeutics was founded in 2013 and is headquartered in Boston, Massachusetts.
Investors
5AM Ventures
Arboretum Ventures
Bridge Builders Collaborative
Jazz Venture Partners
Pear Therapeutics, Akili Interactive Labs, Pymetrics, Halo Neuroscience
Novartis
Temasek Holdings
Tokopedia, DoorDash, Impossible Foods, Wish, AvidXchange, Carbon, Improbable, Farmer's Business Network, Guardant Health, Rent the Runway
Trustbridge Partners
Funding History
| February 2016 | $22.0M |
|---|---|
| December 2017 | $51.0M |
| December 2018 | $70.7M |
| December 2020 | $87.5M |
| December 2020 | $38.9M |
Management
Chief Executive Officer
Corey McCann
Chief Financial & Operating Officer
Chris Guiffre
Press
fiercebiotech - Nov, 18 2020
news - Nov, 5 2020
bioworld - Sep, 22 2020
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Pear Therapeutics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
